Natural compounds for pediatric cancer treatment

Area of Science:

• Oncology
• Pharmacology
• Natural Products Chemistry

Background:

• There is a critical need for noninvasive therapeutic strategies to combat cancer progression.
• Natural compounds offer a promising avenue to improve patient quality of life, particularly for young individuals undergoing treatment.
• Investigating natural compounds in conjunction with standard therapies is essential for advancing pediatric cancer care.

Purpose of the Study:

• To review the current state of research on natural compounds for cancer treatment.
• To identify promising natural compounds and their mechanisms of action in preclinical and clinical studies.
• To explore the potential of nutraceuticals and functional foods as adjuvant therapies in pediatric oncology.

Main Methods:

• Literature review of preclinical and clinical studies on natural compounds in cancer therapy.
• Analysis of drug discovery studies, including targets, signaling pathways, and modes of action.
• Compilation of data on specific natural compounds with demonstrated efficacy in vitro and in vivo.

Main Results:

• Several natural compounds, including Chebulagic acid, Apigenin, and Curcumin, have shown significant potential in preclinical and clinical settings.
• Specific compounds like Saffron/Crocin, Parthenolide, and Epigallocatechin gallate exhibit promising anti-cancer activities.
• Nutraceuticals and functional food components like Resveratrol and Quercetin may serve as valuable adjuvant therapies.

Conclusions:

• Natural compounds represent a vital resource for developing novel, noninvasive cancer treatments.
• Further research into these compounds can lead to improved therapeutic strategies and better outcomes for pediatric cancer patients.
• Adjuvant therapies derived from natural sources hold potential for enhancing the efficacy of conventional cancer treatments.